Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?

Yıl 2016, Cilt: 33 Sayı: 1, 115 - 116, 01.01.2016

Toplam 0 adet kaynakça vardır.

Diğer ID	JA25ER87SF
Bölüm	Editoryal
Yazarlar	Ricardo Ruiz-villaverde Bu kişi benim Daniel Sánchez-cano Bu kişi benim
Yayımlanma Tarihi	1 Ocak 2016
Yayımlandığı Sayı	Yıl 2016 Cilt: 33 Sayı: 1

APA	Ruiz-villaverde, R., & Sánchez-cano, D. (2016). Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal, 33(1), 115-116.
AMA	Ruiz-villaverde R, Sánchez-cano D. Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal. Ocak 2016;33(1):115-116.
Chicago	Ruiz-villaverde, Ricardo, ve Daniel Sánchez-cano. “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”. Balkan Medical Journal 33, sy. 1 (Ocak 2016): 115-16.
EndNote	Ruiz-villaverde R, Sánchez-cano D (01 Ocak 2016) Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal 33 1 115–116.
IEEE	R. Ruiz-villaverde ve D. Sánchez-cano, “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”, Balkan Medical Journal, c. 33, sy. 1, ss. 115–116, 2016.
ISNAD	Ruiz-villaverde, Ricardo - Sánchez-cano, Daniel. “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”. Balkan Medical Journal 33/1 (Ocak 2016), 115-116.
JAMA	Ruiz-villaverde R, Sánchez-cano D. Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal. 2016;33:115–116.
MLA	Ruiz-villaverde, Ricardo ve Daniel Sánchez-cano. “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”. Balkan Medical Journal, c. 33, sy. 1, 2016, ss. 115-6.
Vancouver	Ruiz-villaverde R, Sánchez-cano D. Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal. 2016;33(1):115-6.